Two Sigma Securities »

Taysha Gene Therapies shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $30k 17k 1.77
2023-09-30 $87k 28k 3.16

More positions owned by Two Sigma Securities

Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Netflix (NFLX)
Advanced Micro Devices Call Option (AMD)
Boeing Company Call Option (BA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Johnson & Johnson Call Option (JNJ)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)

View all positions for Two Sigma Securities

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
Damian Sousa
Cowen And Company
Susquehanna International
T. Rowe Price Associates
Schonfeld Strategic Advisors
Quantum Private Wealth

View all funds holding Taysha Gene Therapies